1380697-50-6

Upstream product

• 6751-75-3 2-bromoresorcinol 
• 108-24-7 acetic anhydride 

Downstream Products

• 1380697-51-7 2-bromo-3-[(2-methyl-2-propen-1-yl)oxy]phenyl acetate 
• 1232362-02-5 3,3-dimethyl-2,3-dihydro-1-benzofuran-4-ol 
• 1380697-53-9 3,3-dimethyl-4-[(4-nitrophenyl)oxy]-2,3-dihydro-1-benzofuran 
• 1380697-54-0 4-[(3,3-dimethyl-2,3-dihydro-1-benzofuran-4-yl)oxy]aniline 
• 1380697-55-1 1,1-dimethylethyl [(1R)-2-({4-[(3,3-dimethyl-2,3-dihydro-1-benzofuran-4-yl)oxy]phenyl}amino)-1-methyl-2-oxoethyl]carbamate 
• 1380697-56-2 N₁-{4-[(3,3-dimethyl-2,3-dihydro-1-benzofuran-4-yl)oxy]phenyl}-D-alaninamide 
• 1380696-16-1 (5R)-3-{4-[(3,3-dimethyl-2,3-dihydro-1-benzofuran-4-yl)oxy]phenyl}-5-methyl-2,4-imidazolidinedione 

Relevant academic research and scientific papers

HYDANTOIN MODULATORS OF KV3 CHANNELS

The invention provides compounds of formula (I): Said compounds being inhibitors of Kv3 channels and of use in the prophylaxis or treatment of related disorders.

NOVEL COMPOUNDS

The invention provides compounds of formula (I): Said compounds being modulators of Kv3 channels and of use in the prophylaxis or treatment of related disorders.

HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS

The invention provides compounds of formula (I): Said compounds being modulators of Kv3 channels and of use in the prophylaxis or treatment of related disorders.

HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS

The invention provides compounds of formula (I): Said compounds being inhibitors of Kv3 channels and of use in the prophylaxis or treatment of related disorders.

HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS

The invention provides compounds of formula (I): Said compounds being inhibitors of Kv3 channels and of use in the prophylaxis or treatment of related disorders.